Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-23-003059
Date:2023-01-27
Issuer: JASPER THERAPEUTICS, INC. (JSPR)
Original Submission Date:

Reporting Person:

CARLYLE GROUP INC.
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220S WASHINGTON, DC 20004-2505

Reporting Person:

ABINGWORTH LLP
38 JERMYN STREET,
LONDON, ENGLAND, X0 SW1Y 6DN

Reporting Person:

CARLYLE HOLDINGS I GP INC.
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220S WASHINGTON, DC 20004-2505

Reporting Person:

CARLYLE HOLDINGS I GP SUB L.L.C.
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220S WASHINGTON, DC 20004-2505

Reporting Person:

CARLYLE HOLDINGS I L.P.
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220S WASHINGTON, DC 20004-2505

Reporting Person:

CG SUBSIDIARY HOLDINGS L.L.C.
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220S WASHINGTON, DC 20004-2505

Reporting Person:

TC GROUP, LLC
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220S WASHINGTON, DC 20004-2505

Reporting Person:

CARLYLE INVESTMENT MANAGEMENT LLC
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220S WASHINGTON, DC 20004-2505

Reporting Person:

CARLYLE GENESIS UK LLC
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVE. NW, SUITE 220S WASHINGTON, DC 20004-2505

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
VOTING COMMON STOCK 2023-01-27 P 3,133,333 a $1.50 8,761,891 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 reflects securities held of record by abingworth bioventures vii lp ("abv vii"). abv vii has delegated to abingworth llp all investment and dispositive power over the securities held of record by abv vii.
f2 the carlyle group inc., which is a publicly traded entity listed on nasdaq, is the sole shareholder of carlyle holdings i gp inc., which is the sole member of carlyle holdings i gp sub l.l.c., which is the general partner of carlyle holdings i l.p., which, with respect to the securities reported herein, is the managing member of cg subsidiary holdings l.l.c., which is the managing member of tc group, l.l.c., which is the managing member of carlyle investment management, l.l.c., which is the sole member of carlyle genesis uk llc, which is the principal member of abingworth llp. accordingly, each of the foregoing entities may be deemed to share beneficial ownership of the securities held of record by abv vii, but each disclaims beneficial ownership of such securities except to the extent of their pecuniary interest therein, if any.
WhaleWisdom Logo

Elevate your investments